Unipharma Co., Ltd.

Unipharma Co., Ltd. financial statements

Unipharma Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueTWD 88.44MEODHD
Net income−TWD 40.54MEODHD
Cash and equivalentsTWD 29MEODHD

Unipharma Co., Ltd. financials on 6ix · Unipharma Co., Ltd. on 6ix